XT
TNXP icon

XTX Topco’s Tonix Pharmaceuticals TNXP Stock Holding History

XTX Topco’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,296
Closed -$490K – 3801
2025
Q3 		$490K Buy
+20,296
New +$753K 0.03% 1089
2024
Q2 		– Sell
-23
Closed -$13.4K – 2466
2024
Q1 		$13.4K Buy
+23
New +$24.8K ﹤0.01% 1653
2022
Q3 		– Sell
-1
Closed -$29K – 1391
2022
Q2 		$29K Buy
+1
New +$73.8K 0.01% 793

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

XTX Topco's TNXP Position: Q4 2025 in Review

XTX Topco sold out of Tonix Pharmaceuticals (TNXP) in Q4 2025, closing a stake of 20,296 shares — an estimated $490K sold.

XTX Topco first reported a position in TNXP in Q2 2022 and held it in 3 quarters. The position peaked at $490K in Q3 2025. 70 funds tracked by Wall St. Rank hold TNXP as of Q4 2025.

  • XTX Topco reported no remaining Tonix Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • XTX Topco sold 20,296 Tonix Pharmaceuticals shares in Q4 2025, an estimated $490K.
  • XTX Topco first reported a position in Tonix Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • XTX Topco's Tonix Pharmaceuticals position peaked at $490K in Q3 2025.
  • 70 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.